Infographic: Investment Opportunities in Biotech
Infographic: Investment Opportunities in Biotech
With the world evolving at an unprecedented pace, nearly every sector is being disrupted in some way or another.
In transportation, EVs were spearheaded by Tesla, which emerged as the first new American automaker in decades, and is now one of the world’s most valuable companies. Similarly, in the realm of AI, OpenAI has taken a leading position in large language models, demonstrating the immense potential of the technology.
Now, we turn our attention to biotech, an industry that is developing innovative treatments at an accelerated pace. In this graphic from sponsor MSCI, we explain the growing pipeline of biotech treatments, and why this could benefit investors.
Growth in Clinical Drug Trials
A clinical drug trial is a study performed on people to evaluate the effectiveness of a medical intervention. Since 2000, the number of trials initiated annually has grown by over 1,300%.
| Drug Trial Type | 2000 | 2010 | 2020 | 2022 |
|---|---|---|---|---|
| Monoclonal antibody | 60 | 623 | 1,833 | 1,685 |
| Protein & peptide therapeutics | 172 | 1,058 | 1,771 | 1,567 |
| Vaccine | 80 | 594 | 1,259 | 915 |
| Recombinant antibody | 50 | 513 | 984 | 860 |
| Cell therapy | 56 | 277 | 548 | 502 |
| Gene-Modified Cell Therapy | 16 | 148 | 355 | 423 |
| DNA & RNA therapeutics | 7 | 56 | 475 | 346 |
| Other biotechnology product | 28 | 236 | 362 | 347 |
| Total | 469 | 3,505 | 7,587 | 6,645 |
Behind every new treatment is an innovative company working to develop it. Thus, as the number of clinical trials grows, so too does the size of the investment universe.
Unfortunately, identifying suitable companies for investment is rather difficult. While a disease may have thousands of potential medicines, only one may ultimately receive FDA approval. This approval process can also take over a decade because treatments must pass several phases of testing.
Introducing the MSCI Life Sciences Indexes
To capture investment opportunities in biotech, MSCI has released a suite of thematic indexes that focus on key growth categories such as oncology and virology.
Developed in collaboration with Royalty Pharma, the world’s largest buyer of pharmaceutical royalties, the MSCI Life Sciences Indexes are designed to gauge the performance of pioneering companies within the biotech space.
These unique indexes can be used to benchmark growth, facilitate portfolio construction, and enhance investment research.
Explore the MSCI Life Sciences Indexes now
-
Politics14 hours agoHow Do Chinese Citizens Feel About Other Countries?
What is the Chinese public’s view of world powers? This visual breaks down Chinese sentiment towards other countries.
-
United States6 days agoMapped: The Safest Cities in the U.S.
How safe is small town America? This map reveals the safest cities in the U.S. in terms of the total crime rate per every 1,000 residents.
-
Countries7 days agoMapped: World’s Top 40 Largest Military Budgets
War in Europe has caused Ukraine’s military spend to jump up by 640%. How do the world’s largest military budgets compare?
-
Cities1 week agoMapped: The Most Dangerous Cities in the U.S.
This map shows the most dangerous cities in the U.S. in terms of the violent crime rate per 1,000 residents.
-
Maps2 weeks agoVintage Viz: The World’s Rivers and Lakes, Organized Neatly
Rivers and lakes have played important roles throughout history. This Vintage Viz looks at these bodies of water from the viewpoint of 1850.
-
Jobs1 month agoVisualizing Annual Working Hours in OECD Countries
Where do people work the most? Explore our analysis of the average annual working hours across OECD countries.
